Clinical Trials on Glabellar Furrows
Total 163 results
-
Oregon Health and Science UniversityAllerganCompletedGlabellar Furrows
-
Daewoong Pharmaceutical Co. LTD.CompletedGlabellar LinesKorea, Republic of
-
AllerganCompleted
-
Medy-ToxCompletedGlabellar LinesUnited States, Belgium, Russian Federation
-
CKD Bio CorporationCompletedGlabellar LinesKorea, Republic of
-
IpsenCompleted
-
AllerganCompletedGlabellar LinesGermany
-
Huons Co., Ltd.CompletedGlabellar LinesKorea, Republic of
-
GlaxoSmithKlineCompleted
-
Advanced Cosmetic InterventionCompletedGlabellar FurrowingUnited States, Canada
-
AbbVieRecruitingGlabellar LinesChina, Taiwan
-
HugelRecruitingGlabellar LinesKorea, Republic of
-
AbbVieCompletedGlabellar LinesUnited States, Canada, Germany, Hungary, Poland
-
Galderma R&DCompleted
-
AllerganCompleted
-
AllerganCompleted
-
IpsenCompletedGlabellar LinesFrance, Germany, United Kingdom
-
BMI KoreaCompletedGlabellar LinesKorea, Republic of
-
IpsenCompletedGlabellar LinesAustralia, Brazil, Czechia, Kazakhstan, Lebanon, Russian Federation, Turkey, Ukraine
-
Mentor Worldwide, LLCSynteract, Inc.CompletedGlabellar RhytidesUnited States
-
Revance Therapeutics, Inc.RecruitingGlabellar Frown LinesUnited States
-
ATGC Co., Ltd.RecruitingGlabellar Frown LinesKorea, Republic of
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Galderma R&DCompleted
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
Protox Inc.CompletedGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown LinesRussian Federation
-
Huons Co., Ltd.UnknownGlabellar Frown LinesKorea, Republic of
-
Protox Inc.Not yet recruitingGlabellar Frown Lines
-
Protox Inc.CompletedGlabellar Frown LinesKorea, Republic of
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
IpsenCompleted
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States, Canada
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
ATGC Co., Ltd.CompletedGlabellar Frown LinesKorea, Republic of
-
Evolus, Inc.PPDCompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.CompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.PPDCompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.PPDCompletedA Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001Glabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesCanada
-
AllerganCompletedGlabellar Frown LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedGlabellar Frown LinesUnited Kingdom, Germany, Austria
-
Bonti, Inc.CompletedGlabellar Frown Lines (GL)United States
-
Galderma R&DCompletedGlabellar Frown Lines | Canthal LinesUnited States